BetterLife Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BETRF research report →
About the company
BetterLife Pharma Inc. , a biotechnology firm headquartered in Vancouver, Canada, specializes in researching and bringing to market therapeutic compounds designed to address neurological disorders across the globe. The company's core focus involves refining and advancing drug candidates derived from interferon-based technologies, which are intended to leverage the immune system to combat viral infections.
- CEO
- Ahmad Doroudian
- IPO
- 2010
- Employees
- 7
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $21.21M
- P/E
- -15.50
- P/S
- 0.00
- P/B
- -3.02
- EV/EBITDA
- -17.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 19.88%
- ROIC
- 32.83%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,497,847 · 57.45%
- EPS
- $-0.01 · 64.08%
- Op Income
- $-1,811,448
- FCF YoY
- 69.02%
- 52W High
- $0.15
- 52W Low
- $0.03
- 50D MA
- $0.06
- 200D MA
- $0.05
- Beta
- 0.20
- Avg Volume
- 79.72K
Get TickerSpark's AI analysis on BETRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 31, 14 | Doroudian Ahmad | other | 0 |
| Jan 31, 14 | Doroudian Ahmad | other | 0 |
| Jan 31, 11 | Doroudian Ahmad | other | 0 |
| Jan 31, 11 | Doroudian Ahmad | other | 0 |
| May 25, 10 | Doroudian Ahmad | other | 800,000 |
| Jul 30, 10 | Doroudian Ahmad | buy | 500,000 |
| Apr 13, 10 | Doroudian Ahmad | other | 0 |
| Apr 13, 10 | Doroudian Ahmad | other | 0 |
| Feb 5, 15 | BORMANN-KENNEDY BARBARA-JEAN ANNE | other | 0 |
| Dec 6, 10 | ONG MOIRA | other | 0 |
Our BETRF coverage
Recent articles, reports, and earnings notes.
No research on BETRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BETRF report →Similar companies
Peers in the same neighborhood.